OSCR

Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice.

Overview

Authors: Jieyu Ji1, You Wang1, Shanglan Qu1,2, Xin Peng1, Ruixue Ma1, Hanwei Li1, Jinlong Chang1, Lijuan Li1, Yanjiao Li1, Zhiting Gong1
ORCID iDs: Zhiting Gong
  1. School of Medicine, Dali University, 671003 Dali, Yunnan, China
  2. School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, 47500 Subang Jaya, Selangor, Malaysia
Institutions: Dali University (China); Taylor's University (Malaysia)
Journal: Alpha psychiatry, volume 27, issue 4, article 51694
Dates: received 10 March 2026; accepted 11 May 2026; published online 17 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.31083/ap51694 · PMID 42694897 · PMCID PMC13540018 · OpenAlex W7207612184
Open access: hybrid, a free copy (OpenAlex)
Categories: genetics / omics (modality), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning, Preprocessing
Keywords: tyrosine kinase inhibitors, anxiety, imatinib, prefrontal cortex, metabolomics, sphingolipids
Topic: Chronic Myeloid Leukemia Treatments (Hematology, Medicine), according to OpenAlex
Funding: National Natural Science Foundation of China (NSFC) (82360231); Yunnan Basic Research Program General Project (202401AT070075); Young Scientists Fund for Basic Research of Local Universities in Yunnan Province (202301BA070001-127); Yunnan Provincial Joint Basic Research Project for Local Undergraduate Colleges and Universities (202501BA070001-044); Dali University Undergraduate Research Fund Project (KYSX2024237)
Citations: not cited yet (Europe PMC); 63 references in the paper

Abstract

Background: Anxiety-related symptoms are frequently reported in patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitor (TKI) therapy. However, the role of TKIs, including imatinib, in development of anxiety remains unclear. The prefrontal cortex (PFC) is closely associated with anxiety-like behaviors, and its metabolic components, particularly lipid- and myelin-related metabolites, are involved in their regulation. Whether imatinib affects brain metabolism remains unknown. This study aimed to evaluate the effects of imatinib on anxiety-like behaviors and to investigate associated metabolic alterations in the PFC.

Methods: Anxiety-like behaviors were assessed using a battery of behavioral assays in imatinib-treated mice. PFC tissues from imatinib-treated and control mice were subjected to untargeted metabolomic analysis.

Results: Imatinib-treated mice exhibited selective alterations in anxiety-like behaviors. Metabolomic analysis revealed distinct metabolic profiles between the two groups, with significant changes in lipid-related pathways, particularly sphingolipid metabolism. These findings extend the current understanding of the metabolic basis of anxiety-like behaviors and suggest that TKI treatment may influence neuropsychiatric processes through metabolic remodeling of the PFC.

Conclusions: This study highlights a potential link between TKI therapy and brain metabolism and provides a framework for understanding the neurobiological basis of anxiety-related effects. These findings may inform future research on the neuropsychiatric consequences of targeted cancer therapies.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Availability of Data and Materials

The datasets generated during the current study have been deposited in Mendeley Data and are publicly available at: https://data.mendeley.com/datasets/6p9vp3vj3d/1.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 6 keywords, 5 funders, 62 references.

Cite

This paper

Ji, J., Wang, Y., Qu, S., Peng, X., Ma, R., Li, H., Chang, J., Li, L., Li, Y., & Gong, Z. (2026). Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice. Alpha psychiatry, 27(4), 51694. https://doi.org/10.31083/ap51694

BibTeX

@article{ji2026imatinib,
author = {Ji, Jieyu and Wang, You and Qu, Shanglan and Peng, Xin and Ma, Ruixue and Li, Hanwei and Chang, Jinlong and Li, Lijuan and Li, Yanjiao and Gong, Zhiting},
title = {{Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice}},
journal = {Alpha psychiatry},
year = {2026},
month = aug,
volume = {27},
number = {4},
pages = {51694},
publisher = {IMR Press},
issn = {2757-8038},
doi = {10.31083/ap51694},
url = {https://doi.org/10.31083/ap51694},
pmid = {42694897},
pmcid = {PMC13540018}
}

RIS

TY - JOUR
AU - Ji, Jieyu
AU - Wang, You
AU - Qu, Shanglan
AU - Peng, Xin
AU - Ma, Ruixue
AU - Li, Hanwei
AU - Chang, Jinlong
AU - Li, Lijuan
AU - Li, Yanjiao
AU - Gong, Zhiting
TI - Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice
T2 - Alpha psychiatry
J2 - Alpha Psychiatry
PY - 2026
DA - 2026/08/17
VL - 27
IS - 4
SP - 51694
SN - 2757-8038
PB - IMR Press
DO - 10.31083/ap51694
UR - https://doi.org/10.31083/ap51694
LA - en
ER -

CSL-JSON

{
"id": "10.31083/ap51694",
"type": "article-journal",
"title": "Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice",
"container-title": "Alpha psychiatry",
"author": [
{
"family": "Ji",
"given": "Jieyu"
},
{
"family": "Wang",
"given": "You"
},
{
"family": "Qu",
"given": "Shanglan"
},
{
"family": "Peng",
"given": "Xin"
},
{
"family": "Ma",
"given": "Ruixue"
},
{
"family": "Li",
"given": "Hanwei"
},
{
"family": "Chang",
"given": "Jinlong"
},
{
"family": "Li",
"given": "Lijuan"
},
{
"family": "Li",
"given": "Yanjiao"
},
{
"family": "Gong",
"given": "Zhiting"
}
],
"container-title-short": "Alpha Psychiatry",
"volume": "27",
"issue": "4",
"page": "51694",
"DOI": "10.31083/ap51694",
"PMID": "42694897",
"PMCID": "PMC13540018",
"ISSN": "2757-8038",
"publisher": "IMR Press",
"URL": "https://doi.org/10.31083/ap51694",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12974-023-02862-2
Influenza A virus infection disrupts oligodendrocyte homeostasis and alters the myelin lipidome in the adult mouse.
Journal: Journal of neuroinflammation
In common: genetics / omics, other condition, mouse, 1 other category, 3 references
[2] doi:10.1038/s42255-025-01367-x [code]
DDHD2 provides a flux of saturated fatty acids for neuronal energy and function.
Journal: Nature metabolism
In common: mouse, cellular / molecular, 3 references
[3] doi:10.1038/s42003-023-05147-9
An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis.
Journal: Communications biology
In common: other condition, mouse, cellular / molecular, 2 references
[4] doi:10.1371/journal.pbio.3003192
Seizure evolution in a mouse model of West syndrome involves complex and time-dependent synapse remodeling, gliosis and alterations in lipid metabolism.
Journal: PLoS biology
In common: genetics / omics, mouse, cellular / molecular, 2 references
[5] doi:10.1038/s41598-026-42518-8
Fingolimod normalizes metabolic signatures associated with synaptic plasticity and memory in APP/PS1 model: Sphingosine-1-phosphate receptor a therapeutic target for Alzheimer's.
Journal: Scientific reports
In common: genetics / omics, mouse, cellular / molecular, 2 references
[6] doi:10.1186/s40478-026-02391-y
Neuro-glial lipid imbalance in a Drosophila model of amyotrophic lateral sclerosis 8.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 2 references
[7] doi:10.1093/bib/bbag331 [code]
SPOmiAlign: a modality-agnostic computational framework for multimodal spatial omics alignment enabled by a feature matching foundation model.
Journal: Briefings in bioinformatics
In common: genetics / omics, mouse, 2 references
[8] doi:10.1038/s42003-025-09088-3
Neural and molecular changes during a mind-body reconceptualization, meditation, and open label placebo healing intervention.
Journal: Communications biology
In common: genetics / omics, cellular / molecular, 2 references
[9] doi:10.1080/15548627.2025.2551676
A novel <i>C. elegans</i> model for MAPT/Tau spreading reveals genes critical for endolysosomal integrity and seeded MAPT/Tau aggregation.
Journal: Autophagy
In common: other condition, cellular / molecular, 2 references
[10] doi:10.1038/s41398-026-04214-z
Regulation of oligodendrocyte metabolism and myelination by acetyl-L-carnitine in a mouse model of post-weaning social isolation.
Journal: Translational psychiatry
In common: mouse, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.